Identification and Characterization of a High Vancomycin-Resistant Staphylococcus aureus Harboring VanA Gene Cluster Isolated from Diabetic Foot Ulcer

Authors

1 Research Centre of Gastroenterology and Liver Diseases (RCGLD) in Shahid Beheshti University, Tehran, Iran

2 Department of Microbiology, Institute Pasteur of Iran, Tehran, Iran

Abstract

Objective(s)
Staphylococcus aureus is a common cause of human infection, and emergence of vancomycin-resistance S. aureus  is a great concern for treatment of methicillin-resistant S. aureus,(MRSA) in recent years (MRSA). Here, we report the isolation of high-level VRSA.
Materials and Methods
S. aureus was isolated from foot ulcer of a diabetic woman in Tehran, Iran. Antibiotic susceptibility was determined according to CLSI guidelines. VanA gene cluster PCR was carried out and PCR amplicon of vanA was sequenced.
Results
S. aureus had high-level vancomycin-resistant (MIC 512 ≥ µg/ml). Patient's history revealed that VRSA isolate was acquired through community transmission. Only vanA, vanR and vanS genes were amplified in our isolate. Sequencing revealed that the vanA sequence had high similarity to the vanA sequence of Tn1546.
Conclusion
Although VRSA infection continues to be rare, isolation of community–acquired VRSA is a significant issue and it needs the efforts of public health authorities.
 

Keywords


1. Périchon B, Courvalin P.  Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother  2004; 48:4281–4285.
2. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States. Morb Mortal Wkly Rep 2002; 51:565-567.
3. Saha B, Singh AK, Ghosh A, Bal M. Identification and characterization of a vancomycin resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 2008; 57:72–79.
4. Emaneini  M, Aligholi M, Hashemi FB, Jabalameli F, Shahsavan S, Dabiri H, et al. Isolation of vancomycin-resistant Staphylococcus aureus in a teaching hospital in Tehran. J Hosp Infect 2007; 66:92-93.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement, M100-S16. Clinical and Laboratory Standards.  Institute Wayne, USA: 2006.
6. Jung WK, Hong SK, Lim JY, Lim SK, Kwon NH, Kim JM, et al. Phenotypic and genetic characterization of vancomycin-resistant enterococci from hospitalized humans and from poultry in Korea. FEMS Microbiol Lett  2006; 260:193-200.
7. Miele A, Bandera M,  Goldstein BP. Use of primers selective for vancomycin resistance gene to determine van genotype in enterococci and to study gene organization in vanA isolates. Antimicrob. Agents Chemother 1995; 39:1772-1778.
8. Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 2004; 38:1049-1055.
9. Woodford  N, Adebiyi AA , Palepou MI, Cookson BD. Diversity of vanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 1998; 42:502-508.